-
1
-
-
84875338786
-
Neonatal herpes simplex virus infections
-
23481105, ().:–
-
Pinninti SG, Kimberlin DW, (2013) Neonatal herpes simplex virus infections. Pediatr Clin North Am60: 351–365. doi: 10.1016/j.pcl.2012.12.00523481105
-
(2013)
Pediatr Clin North Am
, vol.60
, pp. 351-365
-
-
Pinninti, S.G.1
Kimberlin, D.W.2
-
2
-
-
0033523873
-
A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group
-
10547406, ().:–
-
Langenberg A, Corey L, Ashley R, Leong W, Straus S, (1999) A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N Engl J Med341: 1432–1438. 10547406
-
(1999)
N Engl J Med
, vol.341
, pp. 1432-1438
-
-
Langenberg, A.1
Corey, L.2
Ashley, R.3
Leong, W.4
Straus, S.5
-
3
-
-
0031017382
-
The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase
-
9023344, ().:–
-
He B, Gross M, Roizman B, (1997) The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proc Natl Acad Sci U S A94: 843–848. 9023344
-
(1997)
Proc Natl Acad Sci U S A
, vol.94
, pp. 843-848
-
-
He, B.1
Gross, M.2
Roizman, B.3
-
4
-
-
59449109932
-
Control of TANK-binding kinase 1-mediated signaling by the gamma(1)34.5 protein of herpes simplex virus 1
-
19010780, ().:–
-
Verpooten D, Ma Y, Hou S, Yan Z, He B, (2009) Control of TANK-binding kinase 1-mediated signaling by the gamma(1)34.5 protein of herpes simplex virus 1. J Biol Chem284: 1097–1105. doi: 10.1074/jbc.M80590520019010780
-
(2009)
J Biol Chem
, vol.284
, pp. 1097-1105
-
-
Verpooten, D.1
Ma, Y.2
Hou, S.3
Yan, Z.4
He, B.5
-
5
-
-
33947715151
-
HSV-1 ICP34.5 confers neurovirulence by targeting the Beclin 1 autophagy protein
-
18005679, . ().:–
-
Orvedahl A, Alexander D, Talloczy Z, Sun Q, Wei Y, et al. (2007) HSV-1 ICP34.5 confers neurovirulence by targeting the Beclin 1 autophagy protein. Cell Host Microbe1: 23–35. 18005679
-
(2007)
Cell Host Microbe
, vol.1
, pp. 23-35
-
-
Orvedahl, A.1
Alexander, D.2
Talloczy, Z.3
Sun, Q.4
Wei, Y.5
-
6
-
-
0025688373
-
Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture
-
2173860, ().:–
-
Chou J, Kern ER, Whitley RJ, Roizman B, (1990) Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture. Science250: 1262–1266. 2173860
-
(1990)
Science
, vol.250
, pp. 1262-1266
-
-
Chou, J.1
Kern, E.R.2
Whitley, R.J.3
Roizman, B.4
-
7
-
-
0028147382
-
ICP34.5 mutants of herpes simplex virus type 1 strain 17syn+ are attenuated for neurovirulence in mice and for replication in confluent primary mouse embryo cell cultures
-
8254758, ().:–
-
Bolovan CA, Sawtell NM, Thompson RL, (1994) ICP34.5 mutants of herpes simplex virus type 1 strain 17syn+ are attenuated for neurovirulence in mice and for replication in confluent primary mouse embryo cell cultures. J Virol68: 48–55. 8254758
-
(1994)
J Virol
, vol.68
, pp. 48-55
-
-
Bolovan, C.A.1
Sawtell, N.M.2
Thompson, R.L.3
-
8
-
-
84923848506
-
Differential reliance on autophagy for protection from HSV encephalitis between newborns and adults
-
25569138, ().:
-
Wilcox DR, Wadhwani NR, Longnecker R, Muller WJ, (2015) Differential reliance on autophagy for protection from HSV encephalitis between newborns and adults. PLoS Pathog11: e1004580. doi: 10.1371/journal.ppat.100458025569138
-
(2015)
PLoS Pathog
, vol.11
, pp. e1004580
-
-
Wilcox, D.R.1
Wadhwani, N.R.2
Longnecker, R.3
Muller, W.J.4
-
9
-
-
84950324040
-
HSV targeting of the host phosphatase PP1α is required for disseminated disease in the neonate and contributes to pathogenesis in the brain
-
().:–
-
Wilcox DR, Muller WJ, Longnecker R, (2015) HSV targeting of the host phosphatase PP1α is required for disseminated disease in the neonate and contributes to pathogenesis in the brain. Proceedings of the National Academy of Sciences USA112: E6937–44.
-
(2015)
Proceedings of the National Academy of Sciences USA
, vol.112
, pp. 44-E6937
-
-
Wilcox, D.R.1
Muller, W.J.2
Longnecker, R.3
-
10
-
-
0345164384
-
Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase
-
9593328, ().:–
-
Gale M, Jr.Katze MG, (1998) Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase. Pharmacol Ther78: 29–46. 9593328
-
(1998)
Pharmacol Ther
, vol.78
, pp. 29-46
-
-
Gale, M.1
Katze, M.G.2
-
11
-
-
0035085975
-
AlaArg motif in the carboxyl terminus of the gamma(1)34.5 protein of herpes simplex virus type 1 is required for the formation of a high-molecular-weight complex that dephosphorylates eIF-2alpha
-
11264356, ().:–
-
Cheng G, Gross M, Brett ME, He B, (2001) AlaArg motif in the carboxyl terminus of the gamma(1)34.5 protein of herpes simplex virus type 1 is required for the formation of a high-molecular-weight complex that dephosphorylates eIF-2alpha. J Virol75: 3666–3674. 11264356
-
(2001)
J Virol
, vol.75
, pp. 3666-3674
-
-
Cheng, G.1
Gross, M.2
Brett, M.E.3
He, B.4
-
12
-
-
70450208398
-
Dephosphorylation of eIF2alpha mediated by the gamma134.5 protein of herpes simplex virus 1 facilitates viral neuroinvasion
-
19759130, . ().:–
-
Verpooten D, Feng Z, Valyi-Nagy T, Ma Y, Jin H, et al. (2009) Dephosphorylation of eIF2alpha mediated by the gamma134.5 protein of herpes simplex virus 1 facilitates viral neuroinvasion. J Virol83: 12626–12630. doi: 10.1128/JVI.01431-0919759130
-
(2009)
J Virol
, vol.83
, pp. 12626-12630
-
-
Verpooten, D.1
Feng, Z.2
Valyi-Nagy, T.3
Ma, Y.4
Jin, H.5
-
13
-
-
0026427039
-
Neurovirulence factor
-
().:
-
McGeoch DJ, Barnett BC, (1991) Neurovirulence factor. Nature353: 609.
-
(1991)
Nature
, vol.353
, pp. 609
-
-
McGeoch, D.J.1
Barnett, B.C.2
-
14
-
-
0029656197
-
The carboxyl terminus of the murine MyD116 gene substitutes for the corresponding domain of the gamma(1)34.5 gene of herpes simplex virus to preclude the premature shutoff of total protein synthesis in infected human cells
-
8523596, ().:–
-
He B, Chou J, Liebermann DA, Hoffman B, Roizman B, (1996) The carboxyl terminus of the murine MyD116 gene substitutes for the corresponding domain of the gamma(1)34.5 gene of herpes simplex virus to preclude the premature shutoff of total protein synthesis in infected human cells. J Virol70: 84–90. 8523596
-
(1996)
J Virol
, vol.70
, pp. 84-90
-
-
He, B.1
Chou, J.2
Liebermann, D.A.3
Hoffman, B.4
Roizman, B.5
-
15
-
-
59849100923
-
Herpes simplex virus infection is sensed by both Toll-like receptors and retinoic acid-inducible gene- like receptors, which synergize to induce type I interferon production
-
19088275, . ().:–
-
Rasmussen SB, Jensen SB, Nielsen C, Quartin E, Kato H, et al. (2009) Herpes simplex virus infection is sensed by both Toll-like receptors and retinoic acid-inducible gene- like receptors, which synergize to induce type I interferon production. J Gen Virol90: 74–78. doi: 10.1099/vir.0.005389-019088275
-
(2009)
J Gen Virol
, vol.90
, pp. 74-78
-
-
Rasmussen, S.B.1
Jensen, S.B.2
Nielsen, C.3
Quartin, E.4
Kato, H.5
-
16
-
-
84884675857
-
Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects
-
23989956, . ().:–
-
Li XD, Wu J, Gao D, Wang H, Sun L, et al. (2013) Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects. Science341: 1390–1394. doi: 10.1126/science.124404023989956
-
(2013)
Science
, vol.341
, pp. 1390-1394
-
-
Li, X.D.1
Wu, J.2
Gao, D.3
Wang, H.4
Sun, L.5
-
17
-
-
84906544279
-
Interferon gamma-inducible protein (IFI) 16 transcriptionally regulates type i interferons and other interferon-stimulated genes and controls the interferon response to both DNA and RNA viruses
-
25002588, . ().:–
-
Thompson MR, Sharma S, Atianand M, Jensen SB, Carpenter S, et al. (2014) Interferon gamma-inducible protein (IFI) 16 transcriptionally regulates type i interferons and other interferon-stimulated genes and controls the interferon response to both DNA and RNA viruses. J Biol Chem289: 23568–23581. doi: 10.1074/jbc.M114.55414725002588
-
(2014)
J Biol Chem
, vol.289
, pp. 23568-23581
-
-
Thompson, M.R.1
Sharma, S.2
Atianand, M.3
Jensen, S.B.4
Carpenter, S.5
-
18
-
-
84863127174
-
Inhibition of TANK binding kinase 1 by herpes simplex virus 1 facilitates productive infection
-
22171259, . ().:–
-
Ma Y, Jin H, Valyi-Nagy T, Cao Y, Yan Z, et al. (2012) Inhibition of TANK binding kinase 1 by herpes simplex virus 1 facilitates productive infection. J Virol86: 2188–2196. doi: 10.1128/JVI.05376-1122171259
-
(2012)
J Virol
, vol.86
, pp. 2188-2196
-
-
Ma, Y.1
Jin, H.2
Valyi-Nagy, T.3
Cao, Y.4
Yan, Z.5
-
19
-
-
84866353521
-
A neuron-specific role for autophagy in antiviral defense against herpes simplex virus
-
22980330, ().:–
-
Yordy B, Iijima N, Huttner A, Leib D, Iwasaki A, (2012) A neuron-specific role for autophagy in antiviral defense against herpes simplex virus. Cell Host Microbe12: 334–345. doi: 10.1016/j.chom.2012.07.01322980330
-
(2012)
Cell Host Microbe
, vol.12
, pp. 334-345
-
-
Yordy, B.1
Iijima, N.2
Huttner, A.3
Leib, D.4
Iwasaki, A.5
-
20
-
-
76249112828
-
Autophagy protects against Sindbis virus infection of the central nervous system
-
20159618, . ().:–
-
Orvedahl A, MacPherson S, Sumpter R, Jr.Talloczy Z, Zou Z, et al. (2010) Autophagy protects against Sindbis virus infection of the central nervous system. Cell Host Microbe7: 115–127. doi: 10.1016/j.chom.2010.01.00720159618
-
(2010)
Cell Host Microbe
, vol.7
, pp. 115-127
-
-
Orvedahl, A.1
MacPherson, S.2
Sumpter, R.3
Talloczy, Z.4
Zou, Z.5
-
21
-
-
84877319309
-
Herpes simplex virus 2 expresses a novel form of ICP34.5, a major viral neurovirulence factor, through regulated alternative splicing
-
23487469, ().:–
-
Tang S, Guo N, Patel A, Krause PR, (2013) Herpes simplex virus 2 expresses a novel form of ICP34.5, a major viral neurovirulence factor, through regulated alternative splicing. J Virol87: 5820–5830. doi: 10.1128/JVI.03500-1223487469
-
(2013)
J Virol
, vol.87
, pp. 5820-5830
-
-
Tang, S.1
Guo, N.2
Patel, A.3
Krause, P.R.4
-
22
-
-
84906990571
-
Up to four distinct polypeptides are produced from the gamma34.5 open reading frame of herpes simplex virus 2
-
25031346, ().:–
-
Korom M, Davis KL, Morrison LA, (2014) Up to four distinct polypeptides are produced from the gamma34.5 open reading frame of herpes simplex virus 2. J Virol88: 11284–11296. doi: 10.1128/JVI.01284-1425031346
-
(2014)
J Virol
, vol.88
, pp. 11284-11296
-
-
Korom, M.1
Davis, K.L.2
Morrison, L.A.3
-
23
-
-
84907454058
-
Herpes simplex virus 2 ICP34.5 confers neurovirulence by regulating the type I interferon response
-
25238641, ().:–
-
Davis KL, Korom M, Morrison LA, (2014) Herpes simplex virus 2 ICP34.5 confers neurovirulence by regulating the type I interferon response. Virology468–470: 330–339. doi: 10.1016/j.virol.2014.08.01525238641
-
(2014)
Virology
, vol.468-470
, pp. 330-339
-
-
Davis, K.L.1
Korom, M.2
Morrison, L.A.3
-
24
-
-
0029961357
-
The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors
-
8876132, . ().:–
-
Andreansky SS, He B, Gillespie GY, Soroceanu L, Markert J, et al. (1996) The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors. Proc Natl Acad Sci U S A93: 11313–11318. 8876132
-
(1996)
Proc Natl Acad Sci U S A
, vol.93
, pp. 11313-11318
-
-
Andreansky, S.S.1
He, B.2
Gillespie, G.Y.3
Soroceanu, L.4
Markert, J.5
-
25
-
-
31144450821
-
Activated MEK suppresses activation of PKR and enables efficient replication and in vivo oncolysis by Deltagamma(1)34.5 mutants of herpes simplex virus 1
-
16414988, . ().:–
-
Smith KD, Mezhir JJ, Bickenbach K, Veerapong J, Charron J, et al. (2006) Activated MEK suppresses activation of PKR and enables efficient replication and in vivo oncolysis by Deltagamma(1)34.5 mutants of herpes simplex virus 1. J Virol80: 1110–1120. 16414988
-
(2006)
J Virol
, vol.80
, pp. 1110-1120
-
-
Smith, K.D.1
Mezhir, J.J.2
Bickenbach, K.3
Veerapong, J.4
Charron, J.5
-
26
-
-
12944272092
-
Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma
-
10845724, . ().:–
-
Rampling R, Cruickshank G, Papanastassiou V, Nicoll J, Hadley D, et al. (2000) Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma. Gene Ther7: 859–866. 10845724
-
(2000)
Gene Ther
, vol.7
, pp. 859-866
-
-
Rampling, R.1
Cruickshank, G.2
Papanastassiou, V.3
Nicoll, J.4
Hadley, D.5
-
27
-
-
50249124770
-
Potential for efficacy of the oncolytic Herpes simplex virus 1716 in patients with oral squamous cell carcinoma
-
18615711, ().:–
-
Mace AT, Ganly I, Soutar DS, Brown SM, (2008) Potential for efficacy of the oncolytic Herpes simplex virus 1716 in patients with oral squamous cell carcinoma. Head Neck30: 1045–1051. doi: 10.1002/hed.2084018615711
-
(2008)
Head Neck
, vol.30
, pp. 1045-1051
-
-
Mace, A.T.1
Ganly, I.2
Soutar, D.S.3
Brown, S.M.4
-
28
-
-
0035901089
-
Intralesional injection of herpes simplex virus 1716 in metastatic melanoma
-
11229673, ().:–
-
MacKie RM, Stewart B, Brown SM, (2001) Intralesional injection of herpes simplex virus 1716 in metastatic melanoma. Lancet357: 525–526. 11229673
-
(2001)
Lancet
, vol.357
, pp. 525-526
-
-
MacKie, R.M.1
Stewart, B.2
Brown, S.M.3
-
29
-
-
49449099065
-
An acutely and latently expressed herpes simplex virus 2 viral microRNA inhibits expression of ICP34.5, a viral neurovirulence factor
-
18678906, . ().:–
-
Tang S, Bertke AS, Patel A, Wang K, Cohen JI, et al. (2008) An acutely and latently expressed herpes simplex virus 2 viral microRNA inhibits expression of ICP34.5, a viral neurovirulence factor. Proc Natl Acad Sci U S A105: 10931–10936. doi: 10.1073/pnas.080184510518678906
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, pp. 10931-10936
-
-
Tang, S.1
Bertke, A.S.2
Patel, A.3
Wang, K.4
Cohen, J.I.5
|